H.C. Wainwright initiated coverage on Oculis Holding AG with a new price target
$OCS
Biotechnology: Pharmaceutical Preparations
Health Care
H.C. Wainwright initiated coverage of Oculis Holding AG with a rating of Buy and set a new price target of $28.00